14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Feb 18, 2020 $94.55 $95.05 $93.49 $94.31 385 193
Feb 14, 2020 $93.94 $95.11 $93.45 $93.66 324 620
Feb 13, 2020 $94.21 $95.10 $93.36 $94.11 308 947
Feb 12, 2020 $94.16 $95.59 $93.45 $95.31 387 835
Feb 11, 2020 $95.26 $95.95 $93.28 $93.68 414 235
Feb 10, 2020 $94.08 $94.99 $93.69 $94.60 373 156
Feb 07, 2020 $93.87 $95.73 $93.50 $94.45 351 959
Feb 06, 2020 $91.73 $94.85 $90.91 $94.51 344 719
Feb 05, 2020 $92.44 $93.99 $90.81 $91.35 538 753
Feb 04, 2020 $94.57 $94.81 $89.63 $91.53 621 139
Feb 03, 2020 $93.00 $94.61 $91.63 $93.02 881 255
Jan 31, 2020 $85.53 $92.38 $84.50 $90.78 1 228 728
Jan 30, 2020 $78.69 $86.89 $78.10 $86.30 1 467 643
Jan 29, 2020 $78.52 $80.49 $78.02 $79.76 1 589 313
Jan 28, 2020 $78.74 $82.00 $73.51 $79.39 8 661 183
Jan 27, 2020 $50.83 $53.25 $50.80 $52.87 327 881
Jan 24, 2020 $53.26 $53.72 $51.90 $52.05 336 414
Jan 23, 2020 $52.84 $53.45 $51.27 $52.76 643 988
Jan 22, 2020 $55.20 $55.47 $52.87 $52.99 804 096
Jan 21, 2020 $56.08 $56.56 $54.02 $54.09 369 297
Jan 17, 2020 $56.26 $56.72 $55.65 $56.14 310 826
Jan 16, 2020 $55.40 $56.90 $54.78 $56.25 617 617
Jan 15, 2020 $55.09 $55.87 $53.87 $54.33 706 601
Jan 14, 2020 $53.41 $55.57 $52.80 $55.43 522 939
Jan 13, 2020 $52.50 $54.16 $52.17 $53.48 406 822
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT